Quick Takeaways
- WEBER CAPITAL MANAGEMENT LLC /ADV filed SCHEDULE 13G/A for Harvard Bioscience Inc Common Stock, $0.01 par value (HBIO).
- Disclosed ownership: 7.3%.
- Date of event: 31 Mar 2025.
WEBER CAPITAL MANAGEMENT LLC /ADV - 31 Mar 2025 SCHEDULE 13G/A Report for Harvard Bioscience Inc Common Stock, $0.01 par value (HBIO)
- Filing Manager
- WEBER CAPITAL MANAGEMENT LLC /ADV
- Reporting Manager
- Weber Capital Management, LLC
- Symbol
- HBIO
- Shares outstanding
- 44,082,369 shares
- Disclosed Ownership
- 3,200,380 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 May 2025, 12:45:14 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 10 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"WEBER CAPITAL MANAGEMENT LLC /ADV disclosed 7.3% ownership in Harvard Bioscience Inc Common Stock, $0.01 par value (HBIO) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 10 Feb 2025.
- Current filing was accepted on 08 May 2025, 12:45.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Weber Capital Management, LLC | 7.3% | 3,200,380 | 0 | 3,200,380 | /s/ Colin Hillberg | Colin Hillberg, Manager |